PDLIM2 suppresses the progression of hepatocellular carcinoma via enhancing lipid peroxidation through promoting the ubiquitin-mediated proteasomal degradation of ARL14EP
Our previous studies have established that PDZ and LIM domain 2 (PDLIM2) played an inhibitory role in the progression of hepatocellular carcinoma (HCC). However, the underlying regulatory mechanisms remain incompletely understood. In this study, we identified ADP-ribosylation factor-like 14 effector protein (ARL14EP)...